BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12462026)

  • 1. [Outcome of immunosuppressive therapy for myelodysplastic syndromes: results of 12 cases from a single institution].
    Miyata A; Yasuda Y; Fujii S; Kikuchi T
    Rinsho Ketsueki; 2002 Oct; 43(10):911-7. PubMed ID: 12462026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].
    Takanashi M; Kadono Y; Tabata Y; Hibi S
    Rinsho Ketsueki; 1999 Oct; 40(10):1093-9. PubMed ID: 10565227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
    Broliden PA; Dahl IM; Hast R; Johansson B; Juvonen E; Kjeldsen L; Porwit-MacDonald A; Sjoo M; Tangen JM; Uggla B; Oberg G; Hellstrom-Lindberg E
    Haematologica; 2006 May; 91(5):667-70. PubMed ID: 16670072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive treatment of the myelodysplastic syndrome].
    Larsen MS; Hasselbalch HC
    Ugeskr Laeger; 2003 Jun; 165(26):2654-7. PubMed ID: 12886548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes.
    Yazji S; Giles FJ; Tsimberidou AM; Estey EH; Kantarjian HM; O'Brien SA; Kurzrock R
    Leukemia; 2003 Nov; 17(11):2101-6. PubMed ID: 12931212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99.
    Passweg JR; Giagounidis AA; Simcock M; Aul C; Dobbelstein C; Stadler M; Ossenkoppele G; Hofmann WK; Schilling K; Tichelli A; Ganser A
    J Clin Oncol; 2011 Jan; 29(3):303-9. PubMed ID: 21149672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive therapy with antithymocyte globulin and cyclosporine for prolonged marrow failure after hemophagocytic syndrome.
    Kaito K; Otsubo H; Takei Y; Usui N; Kobayashi M
    Ann Hematol; 2003 Nov; 82(11):699-701. PubMed ID: 12961029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of aplastic anemia with anti-thymocyte globulin and cyclosporine].
    Ohnishi S; Nakagawa M; Kobayashi N; Ogasawara M; Kiyama Y; Naohara T; Higa T; Kasai M
    Rinsho Ketsueki; 1998 Sep; 39(9):640-4. PubMed ID: 9796396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
    Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
    Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression.
    Xiao L; Qi Z; Qiusheng C; Li X; Luxi S; Lingyun W
    Am J Hematol; 2012 Jan; 87(1):26-31. PubMed ID: 22038646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
    Pongtanakul B; Das PK; Charpentier K; Dror Y
    Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive therapy for patients with refractory anemia.
    Asano Y; Maeda M; Uchida N; Yokoyama T; Osaki K; Shimoda K; Gondo H; Okamura T; Okamura S; Niho Y
    Ann Hematol; 2001 Nov; 80(11):634-8. PubMed ID: 11757721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes.
    Stadler M; Germing U; Kliche KO; Josten KM; Kuse R; Hofmann WK; Schrezenmeier H; Novotny J; Anders O; Eimermacher H; Verbeek W; Kreipe HH; Heimpel H; Aul C; Ganser A
    Leukemia; 2004 Mar; 18(3):460-5. PubMed ID: 14712285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to glycosylphosphatidyl-inositol anchored proteins (GPI-AP) in antithymocyte and antilymphocyte globulin: possible role for the expansion of GPI-AP deficient cells in aplastic anemia.
    Breitinger HH; Rojewski MT; Schrezenmeier H
    Ann Hematol; 2009 Sep; 88(9):889-95. PubMed ID: 19137453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of aplastic anemia responsive to sirolimus combined with cyclosporine.
    He G; Zhang X; Wu D; Sun A; Wang X
    Pediatr Blood Cancer; 2011 Jul; 56(7):1133-5. PubMed ID: 21488160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
    Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
    Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
    Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A and thalidomide in patients with myelodysplastic syndromes: Results of a pilot study.
    Xiao Z; Xu Z; Zhang Y; Qin T; Zhang H; Fang L
    Leuk Res; 2011 Jan; 35(1):61-5. PubMed ID: 20591481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Time course changes in the count of peripheral granulocytes in children with acquired aplastic anemias treated with antithymocyte globulin, cyclosporin A and granulocytic colony stimulating factor].
    Bogacheva NIu; Novichkova GA; Litvinov DV; Khachatrian LA; Baĭdil'dina DD; Shneĭder MM; Suntsova EV; Skorobogatova EV; Maschan AA
    Ter Arkh; 2002; 74(12):71-7. PubMed ID: 12577848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.